152 related articles for article (PubMed ID: 11554736)
1. Cytosolic O-GlcNAc accumulation is not involved in beta-cell death in HIT-T15 or Min6.
Okuyama R; Yachi M
Biochem Biophys Res Commun; 2001 Sep; 287(2):366-71. PubMed ID: 11554736
[TBL] [Abstract][Full Text] [Related]
2. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
Gao Y; Parker GJ; Hart GW
Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
[TBL] [Abstract][Full Text] [Related]
3. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells.
Hanover JA; Lai Z; Lee G; Lubas WA; Sato SM
Arch Biochem Biophys; 1999 Feb; 362(1):38-45. PubMed ID: 9917327
[TBL] [Abstract][Full Text] [Related]
4. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
Haltiwanger RS; Grove K; Philipsberg GA
J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
[TBL] [Abstract][Full Text] [Related]
5. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
6. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog.
Toleman C; Paterson AJ; Shin R; Kudlow JE
Biochem Biophys Res Commun; 2006 Feb; 340(2):526-34. PubMed ID: 16376298
[TBL] [Abstract][Full Text] [Related]
7. The role of O-linked protein glycosylation in beta-cell dysfunction.
Konrad RJ; Kudlow JE
Int J Mol Med; 2002 Nov; 10(5):535-9. PubMed ID: 12373287
[TBL] [Abstract][Full Text] [Related]
8. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2.
Kim SH; Kim YH; Song M; An SH; Byun HY; Heo K; Lim S; Oh YS; Ryu SH; Suh PG
Biochem Biophys Res Commun; 2007 Oct; 362(2):325-9. PubMed ID: 17707335
[TBL] [Abstract][Full Text] [Related]
11. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
Dauphinee SM; Ma M; Too CK
J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
[TBL] [Abstract][Full Text] [Related]
13. Excessive O-GlcNAcylation of proteins suppresses spontaneous cardiogenesis in ES cells.
Kim HS; Park SY; Choi YR; Kang JG; Joo HJ; Moon WK; Cho JW
FEBS Lett; 2009 Aug; 583(15):2474-8. PubMed ID: 19591829
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.
Shanmugasundaram B; Debowski AW; Dennis RJ; Davies GJ; Vocadlo DJ; Vasella A
Chem Commun (Camb); 2006 Nov; (42):4372-4. PubMed ID: 17057847
[TBL] [Abstract][Full Text] [Related]
15. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins.
Roos MD; Xie W; Su K; Clark JA; Yang X; Chin E; Paterson AJ; Kudlow JE
Proc Assoc Am Physicians; 1998; 110(5):422-32. PubMed ID: 9756093
[TBL] [Abstract][Full Text] [Related]
16. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
17. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
Kim EJ; Perreira M; Thomas CJ; Hanover JA
J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
[TBL] [Abstract][Full Text] [Related]
18. Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.
Lee TN; Alborn WE; Knierman MD; Konrad RJ
Biochem Biophys Res Commun; 2006 Dec; 350(4):1038-43. PubMed ID: 17045574
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of O-GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry.
Perreira M; Kim EJ; Thomas CJ; Hanover JA
Bioorg Med Chem; 2006 Feb; 14(3):837-46. PubMed ID: 16214344
[TBL] [Abstract][Full Text] [Related]
20. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
Matthews JA; Acevedo-Duncan M; Potter RL
Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
